List of SBIR/STTR awards granted to Yaso Therapeutics Incorporated
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Yaso Therapeutics Incorporated in May, 2019 for $999,102.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44HD092206-03 | Phase II | 999,102 | May 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Yaso Therapeutics Incorporated in April, 2022 for $298,521.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HD109101-01 | Phase I | 298,521 | April 6, 2022 | |||||||
A SBIR Phase II contract was awarded to Yaso Therapeutics Incorporated in May, 2017 for $1,967,467.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44HD092206-01 | Phase II | 1,967,467 | May 5, 2017 | |||||||
A SBIR Phase II contract was awarded to Yaso Therapeutics Incorporated for $2,000,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI084225-02 | Phase II | 2,000,000 | ||||||||
A SBIR Phase I contract was awarded to Yaso Therapeutics Incorporated for $152,196.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R41AI069659-01 | Phase I | 152,196 | ||||||||
A STTR Phase I contract was awarded to Yaso Therapeutics Incorporated for $152,196.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI069659-01 | Phase I | 152,196 | ||||||||
A SBIR Phase I contract was awarded to Yaso Therapeutics Incorporated for $285,612.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI084225-01A2 | Phase I | 285,612 |
